Latest Advances

  • Condition: Non-alcoholic Fatty Liver Disease
  • Journal: Advances in experimental medicine and biology
  • Treatment Used: Curcumin Phytosome
  • Number of Patients: 80
  • Published —
The aim of this study was to examine the effect of curcumin supplementation on various aspects of non-alcoholic fatty liver disease (NAFLD).
  • Condition: Patients with Nonalcoholic Liver Disease (NAFLD) with or without Diabetes
  • Journal: Frontiers in endocrinology
  • Treatment Used: Various Hypoglycemic Agents
  • Published —
This review of the literature evaluated and compared the therapeutic effects of various hypoglycemic agents in patients with non-alcoholic liver disease (NAFLD) with or without diabetes.
  • Condition: Metabolic Associated Fatty Liver Disease
  • Journal: Frontiers in endocrinology
  • Treatment Used: Glucagon-like Peptide-1 Receptor Agonists
  • Number of Patients: 396
  • Published —
In this study, researchers evaluated the outcomes of using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of metabolic associated fatty liver disease.
  • Condition: Non-alcoholic fatty liver disease (NAFLD
  • Journal: International journal of molecular sciences
  • Treatment Used: Diet, Physical Activity, Drug Therapy
  • Number of Patients: 0
  • Published —
This review discusses treatments for non-alcoholic fatty liver disease (NAFLD).
  • Condition: Chronic Hepatitis C
  • Journal: Medicina (Kaunas, Lithuania)
  • Treatment Used: Direct-Acting Antiviral Drugs
  • Number of Patients: 0
  • Published —
This study evaluated changes in liver fibrosis and the risk of developing hepatocellular carcinoma after direct-acting antiviral drug therapy in patients with chronic hepatitis C virus infection.
  • Condition: Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes
  • Journal: Frontiers in endocrinology
  • Treatment Used: Sodium-Glucose Co-Transporter 2 Inhibitors
  • Number of Patients: 555
  • Published —
The study researched the use of sodium-glucose co-transporter 2 inhibitors for treating non-alcoholic fatty liver disease in Asian patients with type 2 diabetes.
  • Condition: Polycystic Ovarian Syndrome (PCOS)
  • Journal: Lipids in health and disease
  • Treatment Used: Consumption of Canola and Olive Oils vs Sunflower Oil
  • Number of Patients: 72
  • Published —
This study evaluated the effects of the consumption of canola and olive oils versus sunflower oil in women with polycystic ovarian syndrome (hormonal condition that women can get during their childbearing years; PCOS).
  • Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
  • Journal: Complementary therapies in clinical practice
  • Treatment Used: Resveratrol Supplementation
  • Number of Patients: NULL
  • Published —
This study evaluated the effectiveness of resveratrol (antioxidant of grape) supplementation in patients with nonalcoholic fatty liver disease (build up of extra fat in liver cells that is not caused by alcohol; NAFLD).
  • Condition: Patients with Type 2 Diabetes (T2D) with Non-Alcoholic Fatty Liver Diseases (NAFLDs)
  • Journal: BMJ open diabetes research & care
  • Treatment Used: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors
  • Number of Patients: 0
  • Published —
This review of the literature examined the effects of sodium glucose co-transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) with non-alcoholic fatty liver diseases (NAFLDs).
  • Condition: Non-alcoholic Fatty Liver Disease
  • Journal: Metabolism: clinical and experimental
  • Treatment Used: Weight Loss
  • Number of Patients: 2809
  • Published —
In this study, researchers evaluated the effects of weight loss on persons with non-alcoholic fatty liver disease.
  • Condition: Non-Alcoholic Fatty Liver Disease
  • Journal: Complementary therapies in clinical practice
  • Treatment Used: Sumac (Rhus coriaria L.) Powder Supplementation
  • Number of Patients: 84
  • Published —
The study researched the safety and effectiveness of sumac (Rhus coriaria L.) powder supplementation for treating non-alcoholic fatty liver disease.
  • Condition: Hyperlipidemia
  • Journal: Lipids in health and disease
  • Treatment Used: Berberine Ursodeoxycholate (HTD1801)
  • Number of Patients: 50
  • Published —
This study tested the safety and efficacy of using HTD1801 to treat patients with hyperlipidemia.
Showing 1-12 of 239